Story perspectives
Experts Warn: Self-Administered Peptides Risky Amid FDA Review
4/17/2026
1 of 1
Story summary
- A rising number of Americans self-administer peptides purchased online, often without understanding their contents.
- Pinchas Cohen, a scientist at the University of Southern California, warns that peptides should be used only under medical supervision.
- Cohen's lab identifies MOTS-c, a peptide with ties to Jewish tradition.
- The FDA is considering easing restrictions on peptide injections.
